Association of CYP2B6, CYP3A5, and CYP2C19 Genetic Polymorphisms With Sibutramine Pharmacokinetics in Healthy Korean Subjects
about
Simultaneous determination of sibutramine and its active metabolites in human plasma by LC-MS/MS and its application to a pharmacokinetic study.An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs.In vivo quantitative prediction of the effect of gene polymorphisms and drug interactions on drug exposure for CYP2C19 substratesEffects of clopidogrel and clarithromycin on the disposition of sibutramine and its active metabolites M1 and M2 in relation to CYP2B6*6 polymorphism.Effect of CYP2B6 genotype on the pharmacokinetics of sibutramine and active metabolites in healthy subjects.
P2860
Association of CYP2B6, CYP3A5, and CYP2C19 Genetic Polymorphisms With Sibutramine Pharmacokinetics in Healthy Korean Subjects
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Association of CYP2B6, CYP3A5, ...... ics in Healthy Korean Subjects
@ast
Association of CYP2B6, CYP3A5, ...... ics in Healthy Korean Subjects
@en
type
label
Association of CYP2B6, CYP3A5, ...... ics in Healthy Korean Subjects
@ast
Association of CYP2B6, CYP3A5, ...... ics in Healthy Korean Subjects
@en
prefLabel
Association of CYP2B6, CYP3A5, ...... ics in Healthy Korean Subjects
@ast
Association of CYP2B6, CYP3A5, ...... ics in Healthy Korean Subjects
@en
P2093
P2860
P356
P1476
Association of CYP2B6, CYP3A5, ...... ics in Healthy Korean Subjects
@en
P2093
P2860
P304
P356
10.1038/CLPT.2009.145
P407
P577
2009-08-19T00:00:00Z